Docket Management
Docket: 02N-0417 - Patent Listing Requirements and Application of 30-Month Stays on Approval of ANDA
Comment Number: EC -9

Accepted - Volume 4

Comment Record
Commentor Mr. Tim Gilbert Date/Time 2002-12-23 16:50:48
Organization Gilbert's
Category Company

Comments for FDA General
Questions
1. General Comments We have sent via email to the following address, fdadockets@oc.fda.gov, the written comments of Apotex Corp. in response to request for comments on FDA Proposed Rules. We could not attach the written comments of Apotex Corp. via the Electronic Comment Submission Form as this site does not accept electronic file submissions. We trust that you will retrieve this document from the above address, however please let us know if there is anything further you require in order for us to effect the filing of the document. Thank you, Tim Gilbert




EC -9